A carregar...
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature
Erlotinib and gefitinib are among the most widely researched, used and available molecularly targeted therapies for treatment of advanced non-small cell lung cancer (NSCLC). They are both tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR). In the past decade, there have...
Na minha lista:
| Publicado no: | World J Clin Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4259947/ https://ncbi.nlm.nih.gov/pubmed/25493223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i5.858 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|